Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1985-08-19
1988-10-04
Brown, J. R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 21, 514768, 514964, 424108, 424499, 424502, A61K 3736, A61K 3718
Patent
active
047756594
ABSTRACT:
This invention provides injectable semi-solid formulations comprising a pharmaceutically or veterinary active agent, an oil and a suitable glyceride release modifying agent.
REFERENCES:
patent: 2493202 (1950-01-01), Macek
patent: 3869549 (1975-03-01), Geller
Takano et al., cited in Chem. Abstracts, vol. 99:64639.
Gelucire Product Bulletin published by Gattefosse Corporation (1983).
Davis et al., J. Dairy Sci., 66:1980-1982 (1983).
Buckwalter et al., J. of the American Pharmaceutical Assoc. 47, 661-666 (1958).
Chemical Abstracts 52:20922b.
Chemical Abtracts 42:7934d.
Chemical Abstracts 31:5941-5944.
Chemical Abstracts 46:9809g.
Slevin et al., Investigational New Drugs 2, 271-276 (1984).
Chemical Abstracts 52:6731b.
Chemical Abstracts 51:13323f.
Chemical Abstracts 52:15845e.
Chemical Abstracts 51:9100d.
Chemical Abstracts 44:1225i.
Chemical Abstracts 39:4390-4394.
Chemical Abstracts 54:16756g.
Harrison Roger G.
Thakkar Arvind L.
Barclay Bruce J.
Brown J. R.
Eli Lilly and Company
Stone Jacqueline M.
Whitaker Leroy
LandOfFree
Injectable semi-solid formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Injectable semi-solid formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable semi-solid formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2156466